InvestingCongress
  • Investing
  • Business
  • Stock
  • Politics
Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com
previous post
Excellent Gold Intersections Verified at Kiimala Project
next post
Multiple New Multi-Commodity Targets

You may also like

Finlay Minerals Appoints an Executive Chairman, President &...

May 12, 2025

Nuvau Minerals Completes High Resolution Drone MAG Survey

May 12, 2025

Falco Files Requested Documentation for the Horne 5 Project’s...

May 12, 2025

Triumph Gold Discovers a New Silver and Gold...

May 12, 2025

Multiple New Multi-Commodity Targets

May 12, 2025

Excellent Gold Intersections Verified at Kiimala Project

May 11, 2025

Tech 5: OpenAI Restructures, Apple Pursues AI Search,...

May 11, 2025

Crypto Market Recap: Bitcoin Breaks US$100,000, Coinbase Makes...

May 11, 2025

Top 5 Canadian Mining Stocks This Week: Group...

May 11, 2025

Buffett Hands Over Reins, What’s Next for Berkshire’s...

May 9, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development

      May 12, 2025
    • Nuvau Minerals Completes High Resolution Drone MAG Survey

      May 12, 2025
    • Falco Files Requested Documentation for the Horne 5 Project’s Environmental Authorization Process

      May 12, 2025
    • Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon

      May 12, 2025
    • Multiple New Multi-Commodity Targets

      May 12, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investingcongress.com | All Rights Reserved

    InvestingCongress
    • Investing
    • Business
    • Stock
    • Politics